Pliant Therapeutics Inc (STU:9PT)
€ 13.3 0.4 (3.05%) Market Cap: 833.15 Mil Enterprise Value: 487.01 Mil PE Ratio: 0 PB Ratio: 2.23 GF Score: 35/100

Pliant Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 15, 2023 / 08:40PM GMT
Release Date Price: €29 (+2.11%)
Mike Kratky
SVB Securities LLC - Analyst

All right. Good afternoon, everyone. Thanks for joining us here at the SVB Securities Global Biopharma Conference. My name is Mike Kratky. I'm a vice president here at SVB Securities. And I'm very happy to be hosting Pliant today. And joining us from the company are CFO Keith Cummings and CMO Ãric Lefebvre.

So one housekeeping note just before we get going here. For investors joining on webcast, feel free to just submit questions via the webcast portal or just email me directly at [email protected].

So Keith and Ãric, thanks for joining.

Ã;ric Lefebvre
Pliant Therapeutics, Inc. - Chief Medical Officer

Thank you. Pleasure.

Keith Cummings
Pliant Therapeutics, Inc. - CFO

Thanks, Mike.

Mike Kratky
SVB Securities LLC - Analyst

So I think everyone is fairly familiar with the story at this point. But would you mind just giving a quick summary and overview of Pliant for those in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot